Dysregulation of the miRNome unveils a crosstalk between obesity and prostate cancer: miR-107 asa personalized diagnostic and therapeutic tool

Prostate-specific antigen (PSA) is the gold-standard marker to screen prostate cancer (PCa) nowadays. Unfortunately, its lack of specificity and sensitivity makes the identification of novel tools to diagnose PCa an urgent medical need. In this context, microRNAs (miRNAs) have emerged as potential s...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrero-Aguayo, Vicente, Sáez-Martínez, Prudencio, Jiménez-Vacas, Juan M., Moreno-Montilla, M. Trinidad, Montero-Hidalgo, Antonio J., Pérez-Gómez, Jesús M., López-Canovas, Juan L., Porcel-Pastrana, Francisco, Carrasco-Valiente, Julia, Anglada, Francisco J., Gómez-Gómez, Enrique, Yubero-Serrano, Elena M., Ibañez-Costa, Alejandro, Herrera-Martínez, Aura D., Sarmento-Cabral, André, Gahete, Manuel D., Luque, Raúl M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889365/
https://www.ncbi.nlm.nih.gov/pubmed/35282415
http://dx.doi.org/10.1016/j.omtn.2022.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889365/
https://www.ncbi.nlm.nih.gov/pubmed/35282415
http://dx.doi.org/10.1016/j.omtn.2022.02.010

Ejemplares similares